help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Zegher, F.
Right arrow Articles by Grumbach, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Zegher, F.
Right arrow Articles by Grumbach, M. M.

Endocrinology, Vol 123, 658-660, Copyright © 1988 by Endocrine Society


ARTICLES

Hormone ontogeny in the ovine fetus: XXI. The effect of insulin-like growth factor-I on plasma fetal growth hormone, insulin and glucose concentrations

F de Zegher, M Bettendorf, SL Kaplan and MM Grumbach
Department of Pediatrics, University of California, San Francisco 94143.

We infused intravenously recombinant human Insulin-like Growth Factor-I (IGF-I; 1 microgram/kg/min for 120 minutes after an acute dose of 25 micrograms/kg) into chronically catheterized ovine fetuses (124-132 days gestation) to study its effect on the secretion of fetal ovine Growth Hormone (oGH). In all IGF-I infused fetuses, oGH concentrations fell during the infusion. The maximal change in the concentration of oGH (mean +/- SEM) was -54 +/- 10 ng/ml in contrast to +7 +/- 6 ng/ml in saline controls (p less than 0.005), a decrease of 33 +/- 4% (controls: +6 +/- 5%; p less than 0.005). By 60 minutes after the infusion of IGF-I was completed, the concentration of plasma oGH was comparable to control and pre-infusion values. In IGF-I infused fetuses, the mean concentration of insulin also decreased (p less than 0.02), whereas glucose levels remained unaltered. The results suggest that the lack of inhibitory feedback by the relatively low levels of circulating IGF-I is one factor in the hypersecretion of GH by the fetus.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. H. Bloomfield, P. L. van Zijl, M. K. Bauer, H. H. Phua, and J. E. Harding
Effect of pulsatile growth hormone administration to the growth-restricted fetal sheep on somatotrophic axis gene expression in fetal and placental tissues
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E333 - E339.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. Ogilvy-Stuart, S. J. Hands, C. J. Adcock, J. M. P. Holly, D. R. Matthews, V. Mohamed-Ali, J. S. Yudkin, A. R. Wilkinson, and D. B. Dunger
Insulin, Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1, Growth Hormone, and Feeding in the Newborn
J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3550 - 3557.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. d. Zegher, I. Francois, m. van helvoirt, and g. van den berghe
Small as Fetus and Short as Child: From Endogenous to Exogenous Growth Hormone
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2021 - 2026.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society